ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980